Non-Alcoholic Steatohepatitis (NASH)

Receive compensation for participation

Qualified Participants:

• Male & Female Participants ages 18 to 75 years old
• Histologically confirmed NASH per NASH Clinical Research Network criteria as diagnosed by liver biopsy within 90 days of screening
• HbA1c ≤ 10.5% in patients with T2DM managed on a stable dose of antidiabetic medication and/or diet for at least 90 days prior to screening

Now at the following sites: Uniontown, PA.